Literature DB >> 25548858

Independent validation of six melanoma risk prediction models.

Catherine M Olsen1, Rachel E Neale1, Adèle C Green2, Penelope M Webb1, David C Whiteman3.   

Abstract

Identifying people at high risk of melanoma is important for targeted prevention activities and surveillance. Several tools have been developed to classify melanoma risk, but few have been independently validated. We assessed the discriminatory performance of six melanoma prediction tools by applying them to individuals from two independent data sets, one comprising 762 melanoma cases and the second a population-based sample of 42,116 people without melanoma. We compared the model predictions with actual melanoma status to measure sensitivity and specificity. The performance of the models was variable with sensitivity ranging from 97.7 to 10.5% and specificity from 99.6 to 1.3%. The ability of all the models to discriminate between cases and controls, however, was generally high. The model developed by MacKie et al. (1989) had higher sensitivity and specificity for men (0.89 and 0.88) than women (0.79 and 0.72). The tool developed by Cho et al. (2005) was highly specific (men, 0.92; women, 0.99) but considerably less sensitive (men, 0.64; women, 0.37). Other models were either highly specific but lacked sensitivity or had low to very low specificity and higher sensitivity. Poor performance was partly attributable to the use of non-standardized assessment items and various differing interpretations of what constitutes "high risk".

Entities:  

Mesh:

Year:  2014        PMID: 25548858     DOI: 10.1038/jid.2014.533

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  41 in total

1.  Translating clinical research into clinical practice: impact of using prediction rules to make decisions.

Authors:  Brendan M Reilly; Arthur T Evans
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391

2.  A risk model for prediction of lung cancer.

Authors:  Margaret R Spitz; Waun Ki Hong; Christopher I Amos; Xifeng Wu; Matthew B Schabath; Qiong Dong; Sanjay Shete; Carol J Etzel
Journal:  J Natl Cancer Inst       Date:  2007-05-02       Impact factor: 13.506

3.  Development of a targeted risk-group model for skin cancer screening based on more than 100,000 total skin examinations.

Authors:  S Guther; K Ramrath; D Dyall-Smith; M Landthaler; W Stolz
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-03-04       Impact factor: 6.166

4.  Development of an individual score for melanoma risk.

Authors:  Gaelle Quéreux; Dominique Moyse; Yves Lequeux; Olivier Jumbou; Anabelle Brocard; Daniel Antonioli; Brigitte Dréno; Jean-Michel Nguyen
Journal:  Eur J Cancer Prev       Date:  2011-05       Impact factor: 2.497

Review 5.  Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force.

Authors:  Tracy Wolff; Eric Tai; Therese Miller
Journal:  Ann Intern Med       Date:  2009-02-03       Impact factor: 25.391

6.  Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.

Authors:  C Garbe; P Büttner; J Weiss; H P Soyer; U Stocker; S Krüger; M Roser; J Weckbecker; R Panizzon; F Bahmer
Journal:  J Invest Dermatol       Date:  1994-05       Impact factor: 8.551

7.  Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups.

Authors:  R M MacKie; P McHenry; D Hole
Journal:  Lancet       Date:  1993-06-26       Impact factor: 79.321

8.  Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study.

Authors:  Maria Concetta Fargnoli; Domenico Piccolo; Emma Altobelli; Federica Formicone; Sergio Chimenti; Ketty Peris
Journal:  Melanoma Res       Date:  2004-04       Impact factor: 3.599

Review 9.  A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance.

Authors:  Catherine Meads; Ikhlaaq Ahmed; Richard D Riley
Journal:  Breast Cancer Res Treat       Date:  2011-10-22       Impact factor: 4.872

Review 10.  Risk prediction models for melanoma: a systematic review.

Authors:  Juliet A Usher-Smith; Jon Emery; Angelos P Kassianos; Fiona M Walter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-03       Impact factor: 4.254

View more
  7 in total

1.  Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.

Authors:  Fangyi Gu; Ting-Huei Chen; Ruth M Pfeiffer; Maria Concetta Fargnoli; Donato Calista; Paola Ghiorzo; Ketty Peris; Susana Puig; Chiara Menin; Arcangela De Nicolo; Monica Rodolfo; Cristina Pellegrini; Lorenza Pastorino; Evangelos Evangelou; Tongwu Zhang; Xing Hua; Curt T DellaValle; D Timothy Bishop; Stuart MacGregor; Mark I Iles; Matthew H Law; Anne Cust; Kevin M Brown; Alexander J Stratigos; Eduardo Nagore; Stephen Chanock; Jianxin Shi; Melanoma Meta-Analysis Consortium; MelaNostrum Consortium; Maria Teresa Landi
Journal:  Hum Mol Genet       Date:  2018-12-01       Impact factor: 6.150

2.  Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.

Authors:  Isabelle Kaiser; Sonja Mathes; Annette B Pfahlberg; Wolfgang Uter; Carola Berking; Markus V Heppt; Theresa Steeb; Katharina Diehl; Olaf Gefeller
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

Review 3.  Nanoparticle-Based Combination Therapy for Melanoma.

Authors:  Hongbo Chen; Kai Hou; Jing Yu; Le Wang; Xue Chen
Journal:  Front Oncol       Date:  2022-06-28       Impact factor: 5.738

4.  Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines.

Authors:  K Vuong; B K Armstrong; M Drummond; J L Hopper; J H Barrett; J R Davies; D T Bishop; J Newton-Bishop; J F Aitken; G G Giles; H Schmid; M A Jenkins; G J Mann; K McGeechan; A E Cust
Journal:  Br J Dermatol       Date:  2019-09-22       Impact factor: 9.302

5.  MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project.

Authors:  Elena Tagliabue; Sara Gandini; Rino Bellocco; Patrick Maisonneuve; Julia Newton-Bishop; David Polsky; DeAnn Lazovich; Peter A Kanetsky; Paola Ghiorzo; Nelleke A Gruis; Maria Teresa Landi; Chiara Menin; Maria Concetta Fargnoli; Jose Carlos García-Borrón; Jiali Han; Julian Little; Francesco Sera; Sara Raimondi
Journal:  Cancer Manag Res       Date:  2018-05-14       Impact factor: 3.989

6.  'Mind your Moles' study: protocol of a prospective cohort study of melanocytic naevi.

Authors:  Uyen Koh; Monika Janda; Joanne F Aitken; David L Duffy; Scott Menzies; Richard A Sturm; Helmut Schaider; Brigid Betz-Stablein; Tarl Prow; H Peter Soyer; Adele C Green
Journal:  BMJ Open       Date:  2018-09-19       Impact factor: 2.692

7.  Evaluation of the efficacy of 3D total-body photography with sequential digital dermoscopy in a high-risk melanoma cohort: protocol for a randomised controlled trial.

Authors:  Clare Amy Primiero; Aideen M McInerney-Leo; Brigid Betz-Stablein; David C Whiteman; Louisa Gordon; Liam Caffery; Joanne F Aitken; Elizabeth Eakin; Sonya Osborne; Len Gray; B Mark Smithers; Monika Janda; H Peter Soyer; Anna Finnane
Journal:  BMJ Open       Date:  2019-11-10       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.